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Abstract  
Endurance performance depends on the integration of several 
phenotypic traits influenced by multiple environmental and 
genetic factors. Objectives of the study were: (1) to examine the 
genotypic frequencies of the ACE I/D, ACTN3 R577X polymor-
phisms and endurance performance-related phenotypes, (2) to 
evaluate the dynamics of endurance performance parameters 
during a 5-year period in relation to ACE I/D and ACTN3 
R577X genotypes in Estonian young skiers. Determination of 
VO2peak was performed in 58 skiers aged 15-19 years (41 males, 
17 females) during a 5-year period. The control group consisted 
of 322 healthy non-athletic subjects (145 males, 177 females). 
The study groups were genotyped for the ACE I/D and ACTN3 
R577X variants. Frequencies of the ACE ID and ACTN3 RR 
genotypes were significantly higher (p = 0.047 and p = 0.003, 
respectively) and the RX genotype was lower (p = 0.008) in 
young male skiers compared with controls. A significant rela-
tionship was found between change (Δ) of training volume and 
ΔVO2peak (mL·kg-1·min-1) (r = 0.475, p = 0.002). No significant 
main effect was detected between VO2peak (mL·kg-1·min-1) dy-
namics (comparison with the previous age group data) and ACE 
I/D and ACTN3 R577X genotypes interactions (F = 0.571, p = 
0.770 and F = 0.650 and p = 0.705, respectively) in all young 
skiers. Study results indicated a significantly higher frequency 
of the ACE ID and ACTN3 RR genotypes among Estonian 
young male skiers compared with the male control group. Sig-
nificant genotype-related differences in dynamics of VO2peak 
during a 5-year period were not found. In the future, longitudi-
nal research including different gene variants may contribute to 
a better understanding of the nature of endurance performance.  
 
Key words: Genes polymorphisms, endurance capacity, skiing, 
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Introduction 
 
Genetic predisposition has a substantial role in the devel-
opment of athletic physical performance and is character-
ized by a large number of genes polymorphisms while the 
influence of multiple environmental factors is essential on 
gene expression (MacArthur and North, 2005). Endurance 
performance depends mainly on the integration of cardi-
orespiratory fitness, metabolic processes in skeletal mus-
cles and neurological factors, but biomechanical, psycho-
logical, physical, nutritional and other parameters are 
important as well (Joyner and Coyle, 2008; Rusko, 2003). 
The maximal oxygen uptake (VO2max) is recognized as 
one of the major quantitative traits in sports physiology 
and the most common parameter to demonstrate training 
effects. VO2max is influenced by different environmental 
and genetic factors (Rankinen et al., 2000). The maximal 
heritability for VO2max (adjusted for age, sex and body 
mass) in the sedentary cohort of the HERITAGE Family 
Study was observed to be up to 50% (Bouchard et al., 
1998). On average, women’s VO2max values are 10% 
lower compared to men due to higher body fat mass and 
lower levels of haemoglobin (Pate et al., 1987; Durstine et 
al., 1987). During the growth and maturation period in 11-
17-year-old humans, the increase of VO2peak is affected 
primarily by body lean mass (Armstrong and Welsman, 
2001). 
The angiotensin-converting enzyme gene inser-
tion/deletion (ACE I/D) polymorphism (rs4340) and the 
α-actinin-3 gene (ACTN3) R577X polymorphism 
(rs1815739) are two of the most extensively studied genes 
in recent years in association with human physical per-
formance. As part of the renin-angiotensin system, ACE 
(angiotensin-converting enzyme) has an essential role in 
the regulation of cardiovascular function and metabolic 
processes in muscles. ACE catalyses the conversion of 
angiotensin I to physiologically active angiotensin II, 
which causes vasoconstriction and through the release of 
aldosterone influences the regulation of electrolytes and 
water. In addition, ACE reduces the vasodilatory effect of 
bradykinin causing an increase in blood pressure (Thomp-
son and Binder-Macleod, 2006). The functional polymor-
phism of human ACE I/D is related to the presence (inser-
tion, I allele) or absence (deletion, D allele) of a 287-base-
pair (bp) segment in intron 16. Alvarez et al. (2000) have 
reported that the activity of ACE enzyme in the DD ho-
mozygotes is 3-4 times higher than in the II homozygotes. 
The I allele has been associated with improved endurance 
performance and the D allele with higher ACE activity 
and enhanced strength and sprint performance (Myerson 
et al., 1999; Thompson and Binder-Macleod, 2006). On 
the contrary to the previous researches, there are studies 
not showing the correlation between the ACE I/D poly-
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morphism and enhanced physical performance (Rankinen 
et al., 2000; Taylor et al., 1999). 
Another widely investigated gene influencing ath-
letic performance is the α-actinin-3 (ACTN3). The ACTN3 
gene encodes an actinin-binding protein in the sarcomeric 
Z line of fast-twitch muscle fibres of skeletal muscle 
(North et al., 1999; Mills et al., 2001). A common genetic 
variation in the ACTN3 gene is the replacement of the 
arginine (R) with a stop codon (X) at amino acid 577 
(C→T transition at position 1747 in exon 16) (North et 
al., 1999). The R577X polymorphism of the human 
ACTN3 gene results in two variants of alleles: a functional 
R allele and a non-functional X allele (North et al., 1999; 
Mills et al., 2001). Yang et al. (2003) detected a signifi-
cant association between the ACTN3 R577X polymor-
phism and athletic performance. They found significantly 
higher frequencies of the R allele in elite sprint athletes 
than in controls. The non-functional X allele, which leads 
to the α-actinin-3 deficiency, supports better endurance 
ability. Eynon et al. (2012) reported that the ACTN3 XX 
genotype had a higher frequency in endurance athletes, 
and it was more prevalent in world-class endurance ath-
letes compared to national level athletes. On the contrary, 
in the Genathlete study on Caucasian male elite endurance 
athletes conducted by Döring et al. (2010), no association 
between endurance performance and the ACTN3 R577X 
polymorphism was found. Furthermore, a study on Rus-
sian endurance athletes revealed that the α-actinin-3 defi-
ciency may have a negative effect on performance in 
endurance athletes (Ahmetov et al., 2010). Ahmetov et al. 
(2010) disclosed that the XX genotype was significantly 
underrepresented among Russian endurance athletes 
compared with the control group. They pointed out that in 
addition to endurance capability, power and speed com-
ponents are required as well to be successful in different 
endurance-oriented sports events. 
Meta-analysis, which analyses relationships be-
tween the ACE I/D, the ACTN3 R577X genotypes and 
athletic performance conducted by Ma et al. (2013), re-
vealed significant associations of the ACE II genotype 
with enhanced endurance performance and the ACTN3 R 
allele with better power performance. 
Altogether, numerous previous studies have asso-
ciated the ACE I/D and ACTN3 R577X polymorphisms 
with enhanced physical performance, although outcomes 
have been contradictory across investigations. Secondly, 
there are relatively few longitudinal studies observing the 
association of dynamics in training-induced changes in 
endurance performance with gene polymorphisms. 
The primary aim of the present study was to exam-
ine the prevalence of the ACE I/D and ACTN3 R577X 
genotypes in Estonian young skiers compared to a control 
group. The secondary purpose was to evaluate the dynam-
ics of endurance performance parameters during a 5-year 
period in relation to the ACE I/D and ACTN3 R577X 
genotypes in Estonian young skiers. 
   
Methods 
 
Participants 
Participants   in  the  present  study   were   young    cross- 
country and biathlon skiers (hereafter young skiers). The 
total number of subjects was 58 (41 males and 17 fe-
males). 52% of young skiers were current or former Esto-
nian junior national team members. The database of the 
electronic records (eHL) of Tartu University Hospital 
from the period 2002-2013 was used. All study partici-
pants had five consecutive pre-participation health evalua-
tions (PHE) between the ages 15 to 19 years. Study inclu-
sion criteria for young skiers were regular specific cross-
country skiing training during the observed age period, 
and the PHE had to include training characteristics and an 
exercise test on a treadmill determining the maximal 
oxygen uptake peak (VO2peak). The control group consist-
ed of 322 healthy sedentary subjects without previous 
athletic training (145 males and 177 females). Male con-
trols’ mean age was 33.9 ± 13.2 years (height 1.81 ± 0.07 
m, weight 80.0 ± 13.0 kg) and female controls’ mean age 
was 37.1 ± 13.6 years (height 1.67 ± 0.06 m, weight 65.2 
± 11.0 kg). The ethnic origin of all participants was Cau-
casian. 
Research Ethics Committee of the University of 
Tartu (protocol No. 196/M-30, and No. 207/M-9) ap-
proved the study protocol. Written informed consent was 
obtained from each participant. 
 
Anthropometric measurements 
Subjects’ height (m) was measured using a metal anthro-
pometer (± 0.1 cm) and body mass (kg) was determined 
by using clinical scales (± 0.05 kg). The body mass index 
(BMI) was calculated. 
 
Cardiopulmonary exercise test  
All incremental continuous exercise tests were performed 
on the treadmill (Telineyhtymä, Kotka, Finland). A stand-
ardized stress test protocol for cross-country skiers in-
creasing the treadmill inclination and speed was used. All 
tests were performed to volitional exhaustion to obtain the 
parameters of maximal aerobic endurance. It has been 
found that not all individuals achieve the maximum oxy-
gen consumption plateau during maximal exertion (Bas-
sett and Howley, 2000). In this case, the highest level of 
oxygen uptake (VO2peak) attained in an exercise test to 
exhaustion should be evaluated. VO2peak is considered to 
be an indicator in assessing the aerobic capacity of chil-
dren and adolescents (Armstrong and Welsman, 2001). 
VO2peak (absolute, L · min-1 and relative, mL·kg-1·min-1) 
was determined by the direct breath-by-breath method 
using a gas analyzer (Oxycon Pro version 5.2, Hoechberg, 
Germany). The absolute value of VO2peak is influenced by 
age-related overall growth in body size and increase in 
body mass (Bongers et al., 2014). To exclude this main 
phenomenon, we used the relative value of VO2peak 
(mL·kg-1·min-1) to assess the dynamics of VO2peak related 
to the training capacity and investigated genes variants. In 
addition, the duration of the standardized exercise test 
(min) and maximal heart rate (HRmax, beats·min-1) were 
recorded, and exercise tolerance (W·kg-1) was calculated. 
Heart rate was recorded by using a sport-tester (Polar 
Electro, Finland). Gas analysis data were automatically 
calculated for every 30-second period. VO2peak was con-
sidered as the highest VO2 rate achieved within 30 se-
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conds at the end of the exercise test. The criteria for max-
imal exercise test were the following: (1) respiratory 
exchange ratio (RER) equalled at least 1.1; (2) HRmax > 
90% of the age-predicted maximum calculated according 
to the formula 220 – age (Davis, 2006). 
The change in VO2peak (ΔVO2peak; absolute, L·min-
1; relative mL·kg-1·min-1) was obtained by calculating the 
differences of VO2peak between 15 and 19 year-old age 
groups of female and male skiers. The change in exercise 
test duration (Δ duration of exercise test, min) and the 
training volume per week (Δ training hours, h · week1) 
were calculated similarly. Besides, the dynamics of 
VO2peak, duration of exercise test and training volume 
were observed in each age group separately compared 
with the previous age group. 
 
Genotyping 
Peripheral venous blood samples for DNA extraction 
were collected from all study subjects and controls during 
the period 2010-2013. The DNA was extracted from pe-
ripheral venous blood samples in 9 ml EDTA containing 
vacuettes by using the standard salting-out method (Miller 
et al., 1988). The EDTA tubes were stored at -20°C until 
DNA extraction. Isolated DNA was dissolved in Tris-
EDTA (TE) buffer. The purity and concentrations of the 
DNA were measured by a spectrophotometer (NanoDrop, 
ND-1000). The DNA samples were stored at -80°C until 
usage. Genotyping of rs4343 (ACE, C_11942562_20) and 
rs1815739 (ACTN3, C_590093_1) was carried out by 
using the TaqMan® SNP Genotyping Assay (Applied 
Biosystems, Foster City, CA, USA), which is a multiplex 
endpoint assay that detects variants of a single nucleic 
acid sequence. PCR reactions were run on the ABI 7900 
instrument (Applied Biosystems, Foster City, CA, USA) 
by using the following cycling parameters: after the first 
step at 95°C for 10 min, 40 cycles of denaturation at 92°C 
for 15 s and extension at 60°C for 1 min. Genomic DNA 
(20ng/µl) was amplified in a total volume of 5µl contain-
ing 1x Amplification Master Mix (Applied Biosystems, 
Foster City, CA, USA) and 1x probe. Genotypes were 
analysed by using the allelic discrimination function of 
the system.  
 
Statistical analysis 
Statistical analysis was performed using the Statistical 
Package for Social Sciences (SPSS version 22.0 for 
WINDOWS). Descriptive data are presented as means 
(x), standard deviations (SD) and percentages (%). The 
chi-square (χ2-test) test was used to determine significant 
differences between the frequencies of the ACE I/D and 
the ACTN3 R577X genotypes. The dynamics of VO2peak 
(mL·kg-1·min-1) and the duration of the exercise test (min) 
as the change between five time points were analysed 
with repeated analysis of variance (dynamics as a factor 
of five levels). Two-factor ANOVA was used to deter-
mine the interaction between VO2peak (mL·kg-1·min-1) 
dynamics (five levels), the ACE I/D genotypes (three 
levels) and the ACTN3 R577X genotypes (three levels), 
respectively. The Pearson’s correlation coefficient (r) was 
applied to determine the relationships between variables. 
P values of ≤ 0.05 were set as statistically significant.  
 
Results 
 
Anthropometrical, physical performance and training 
characteristics of young skiers by age and sex are present-
ed in Table 1. Among young male skiers, a remarkable 
increase of the training volume (h · week1) was observed 
at the age of 16 years (t = -3.059, p = 0.007). In female 
skiers, no significant changes in the dynamics in training 
hours per week were found up to 18 years, whereas a 
significant increase was observed at the age of 19 (t = -
2.882, p = 0.024). A significant improvement in the dura-
tion of the standardized exercise test performance (min) 
was detected in the 16- and 17-year age groups (t = -
2.317, p = 0.030; t = -2.508, p = 0.018, respectively) 
among young male skiers and in young female skiers of 
18 years in comparison with the previous age group (t = -
3.977, p = 0.002). A statistically significant improvement 
of the absolute VO2peak was found in males at the age of 
16 (t = -3.849, p = 0.001), 17 (t = -3.232, p = 0.003) and 
19 (t = -2.503, p = 0.020) compared with the previous age 
group. However, after correcting the differences for body 
size, the dynamics of relative VO2peak was not significant 
in comparison across all age groups in young male skiers. 
We found a significant positive trend of absolute VO2peak 
as well as relative VO2peak in young female skiers only in 
the 17-year-old age group compared with the previous age 
group (t = -3.535, p = 0.008 and t = -2.386, p = 0.044, 
respectively). 
Changes in performance parameters in young fe-
male and male skiers between the 15 and 19 year-old 
groups are shown in Table 2. 
There were no significant differences in the distri-
bution of the ACE I/D genotypes between young female 
skiers and controls although the prevalence of the ACE II 
genotype compared with controls was higher, 39% and 
23%, respectively (t = 2.177, p = 0.140) and the ACE ID
 
Table 1. Characteristics of young skiers by age and sex groups. All data are presented as means (±SD). 
Age group (yrs) 15 years 16 years 17 years 18 years 19 years 
Gender Male Female Male Female Male Female Male Female Male Female 
Weight (kg) 63.2 (8.0) 58.4 (8.6) 67.2 (8.4)c 60.2 (6.8)b 69.7 (7.8)c 60.6 (5.2)a 71.4 (7.6)c 62.3 (4.4) 72.5 (8.2)c 61.8 (5.0) 
Height (m) 1.77 (.06) 1.67 (.04) 1.80 (.06)c 1.70 (.04)c 1.81 (.06)c 1.69 (.04) 1.82 (5.5)b 1.71 (.04) 1.82 (.06) 1.69 (.04) 
BMI (kg·m-2) 20.2 (1.9) 20.8 (2.3) 20.8 (2.0) 21.0 (1.9) 21.3 (1.8) 21.3 (1.6) 21.5 (1.6) 21.4 (1.5) 21.9 (1.6) 21.6 (1.3) 
TrVol (h·week-1) 8.5 (2.5) 7.0 (1.4) 9.9 (2.7)b 7.6 (2.4) 11.3 (2.9) 9.3 (2.1) 12.4 (2.9) 10.9 (2.9) 13.4 (2.9) 13.2 (3.1)a 
ET duration (min) 24.6 (5.1) 20.5 (3.4) 27.0 (2.2)a 21.1 (2.8) 27.9 (2.0)a 21.9 (2.4) 28.3 (2.2) 23.4 (1.7)b 29.3 (1.6) 24.6 (2.6) 
VO2peak (L·min-1) 4.0 (.6) 3.0 (.3) 4.4 (.5)c 3.1 (.1) 4.7 (.6)b 3.4 (.3)b 4.8 (.7) 3.4 (.3) 5.0 (.5)a 3.5 (.4) 
VO2peak 
(mL·min-1·kg-1) 
64.1 (6.1) 53.9 (5.9) 66.1 (4.7) 53.0 (5.2) 67.0 (4.5) 55.4 (5.5)a 67.6 (5.7) 54.9 (5.0) 68.1 (5.0) 57.1 (5.2) 
a p ≤ 0.05; b p ≤ 0.01; c p ≤ 0.001 compared to the previous age group; TrVol = training volume; ET = exercise test 
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Figure 1. Genotypic frequencies of the ACE I/D polymorphism (rs4340) in young skiers and non-athletic controls. 
* p < 0.05 in comparison with controls (χ2-test). 
 
 
 
 
 
Figure 2. Genotypic frequencies of the ACTN3 R577X polymorphism (rs1815739) in young skiers and non-athletic controls. 
* p < 0.05 in comparison with controls (χ2-test). 
 
Table 2. Changes in performance parameters (Δ) between 15 
and 19 year-old age groups of female and male skiers. All 
data are presented as means (±SD). 
 Young female 
skiers (n=17) 
Young male 
skiers (n=41) 
Δ TrVol (h·week-1) 6.0 (3.6) 5.1 (3.5) 
Δ ET duration (min) 3.5 (4.2) 3.1 (2.9) 
Δ VO2peak  (L·min-1)   .5 ( .4)   .9 ( .6) 
Δ VO2peak  (mL·kg-1·min-1) 3.6 (4.6) 4.0 (5.2) 
 ET = exercise test; TrVol = training volume  
 
genotype was lower, 33% and 50%, respectively (t = 
1.757, p = 0.185). However, the frequency of the ACE ID 
genotype in young male skiers compared with controls 
was statistically higher (t = 3.940, p = 0.047). There was a 
non-significant lower trend of the ACE DD genotype 
among young male skiers compared to the male control 
group (t = 3.465, p = 0.063) (Figure 1). 
In  the distribution of the ACTN3 genotypes among  
young female skiers, there were no subjects carrying the 
ACTN3 XX genotype in comparison with the group of 
female controls (n = 13; 7.4%). Although there was a 
trend towards a higher frequency of the ACTN3 RR geno-
type in female skiers (33.3%) in comparison with female 
controls (15.3%), the difference remained statistically 
non-significant (t = 3.691, p = 0.055). When analysing the 
results of the distribution of the ACTN3 R577X genotypes 
frequencies in male skiers compared with male controls, 
the frequency of the RR genotype was statistically higher 
(t = 9.045, p = 0.003) and the frequency of the RX geno-
type was lower (t = 7.128, p = 0.008) (Figure 2). 
We did not detect any statistically significant rela-
tionships between the ACE I/D, the ACTN3 R577X geno-
types and the ΔVO2peak (Table 3). However, a considera-
ble increase of the ΔVO2peak was observed in female skiers 
with the ACE ID genotype (6.2 ± 5.7 mL·kg-1·min-1, n = 
5) and in male skiers with the ACTN3 XX genotype (7.6 ± 
Mägi et al.  
 
 
 
 
291 
4.8 mL·kg-1·min-1, n = 4), the increase was statistically 
nonsignificant. 
 
Table 3. VO2peak changes (Δ VO2peak, mL · kg-1 · min-1) ac-
cording to the ACE I/D and the ACTN3 R577X genotypes 
between 15 and 19 year-old age groups of female (n =17) and 
male (n = 41) skiers. All data are presented as means (± SD). 
 Young female skiers 
Δ VO2 peak  
Young male skiers 
Δ VO2 peak  
ACE I/D genotypes  
II  2.0 (2.4) (n = 7) 5.3 (5.5) (n = 10) 
ID  6.2 (5.7) (n = 5) 3.2 (5.0) (n = 26) 
DD          3.3 (5.5) (n = 5)     5.0 (6.2) (n =   5) 
ACTN3 R577X genotypes  
RR  3.7 (2.6) (n = 5) 3.8 (4.8) (n = 16) 
RX    3.7 (5.3) (n = 12) 3.4 (5.5) (n = 21) 
XX -     7.6 (4.8) (n = 4) 
 
The correlation analysis showed a statistically sig-
nificant relationship between the Δ training volume and 
the ΔVO2peak (mL·kg-1·min-1) among young male skiers (r 
= 0.475, p = 0.002), but there was no significant relation-
ship between these variables among female skiers (r = 
0.331, p = 0.247). 
According to the two-factor ANOVA analysis, a 
significant main effect of dynamics of the VO2peak 
(mL·kg-1·min-1) was detected in the total study group (F = 
9.592, p < 0.001), as well as in males (F = 6.933, p < 
0.001) and females (F = 5.741, p < 0.001). No significant 
effect was detected between the dynamics of the VO2peak 
(mL·kg-1·min-1) and the ACE I/D genotypes interaction (F 
= 0.571, p = 0.770) or between the dynamics of the 
VO2peak (mL·kg-1·min-1) and the ACTN3 R577X interac-
tion (F = 0.650, p = 0.705) in all young skiers. There were 
no gender differences in all measured interactions.  
 
Discussion 
 
The results of our study revealed a significantly higher 
prevalence of the ACE ID and the ACTN3 RR genotypes 
and lower ACTN3 RX genotypes in male skiers in com-
parison with controls. A trend of a lower frequency of the 
ACE DD was observed among young male skiers com-
pared with male controls. 
Competitive cross-country skiing belongs to the 
group of one of the most demanding sports events. In the 
classification of sports activities by Mitchell et al. (2005), 
which is based on the type and intensity of exercise per-
formed, cross-country skiing is characterized as a sport 
with high dynamic and up to moderate static (depending 
on the technique of skiing) capacities. Regardless of the 
very different length of race distances − from sprint dis-
tances of 1.5 km up to 50 km − all distances require high 
endurance performance (Rusko, 2003). It has been found 
in experimental studies that depending on the terrain 
profile, the proportion of aerobic energy production in 
longer distances can reach up to 90 - 99%, while during 
sprint ski-racing it may be 50% on average (Rusko, 
2003). 
Folland et al. (2000) associated a larger gain in 
muscle strength and hypertrophy after resistance training 
with the D allele of the ACE gene in their study. Muscle 
strength, especially upper body muscle strength plays an 
important role in addition to endurance capacity in com-
petitive cross-country skiing (Alsobrook and Heil, 2009). 
Thus, the combination of the I and D allele of the ACE 
I/D polymorphism may be advantageous for good per-
formance in skiing. In our study, it was not possible to 
distinguish between the sprint and distance skiers because 
young skiers participated in both distances during the 
observed age period. In addition, our results did not con-
firm reliable evidence for the association between the 
ACE II genotype and endurance performance. 
Our findings showed a higher prevalence of the 
ACTN3 RR genotype among young male skiers, which 
does not concur with the evidence from meta-analysis by 
Alfred et al. (2011), where the RR genotype was found 
more common in sprint and power athletes compared with 
controls among Europeans (Alfred et al., 2011). However, 
no evidence was found in this meta-analysis that the X 
allele gives an advantage in endurance performance (Al-
fred et al., 2011). 
Several studies (Alsobrook and Heil, 2009; Paavo-
lainen et al., 1991) emphasize the importance of muscle 
mass and explosive power in the speed of skiing. A higher 
prevalence of the ACTN3 RR genotype among young 
male skiers compared with the male control group (p = 
0.006) in our study may explain the previous argument. In 
a study among Russian endurance athletes, researchers 
found that the ACTN3 X allele was underrepresented in 
Russian endurance athletes and the α-actinin-3 deficiency 
was estimated as one possible limiting factor in improving 
power and strength in endurance events (Ahmetov et al., 
2010). Data of the present study suggest that the distribu-
tion of the ACTN3 R577X genotypes among young male 
and female skiers was different. Although there was a 
statistically significant over-representation of the RR 
genotype in male skiers in comparison with male controls, 
no significant differences between young female skiers 
and female controls were found. One reason for this might 
be a relatively small sample of the female study group (n 
= 17). 
In our study, we did not find a significant associa-
tion between the ACE I/D, the ACTN3 R577X genotypes 
and increase of VO2peak (ΔVO2peak, mL·kg-1·min-1) in either 
the male or female study group. However, a larger in-
crease of the VO2peak (mL·kg-1·min-1) during the 5-year 
training process can be observed among female skiers 
with the ACE ID genotype, but it remained statistically 
nonsignificant (t = 0.760, p = 0.472). On the contrary, the 
ΔVO2peak (mL·kg-1·min-1) in male skiers during the 5-year 
observation period was not associated with the ACE II, ID 
or DD genotype. We detected a recognizable, although 
statistically nonsignificant improvement in the ΔVO2peak 
(mL·kg-1·min-1) among male skiers with the ACTN3 XX 
genotype, which is in agreement with the studies, where a 
higher XX genotype prevalence in endurance sport has 
been found (Eynon et al., 2012; Yang et al., 2003). How-
ever, a limiting factor of the present study is the small 
sub-group of the ACTN3 XX genotype − four subjects of 
41 male skiers. At the same time, Thompson et al. (2006) 
did not find significant associations between the dynamics 
of the VO2max and ACE I/D genotypes after a 6-week 
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training program. In our study, the ΔVO2peak (L·min-1), the 
ΔVO2peak (mL·kg-1·min-1) and the Δ duration of the stand-
ardized exercise test did not show significant associations 
with the ACE I/D and ACTN3 R577X genotypes. We can 
assume that the ACE II and the ACTN3 XX genotypes 
might not provide an advantage in endurance performance 
phenotypes in our study group. The latter supposition 
conforms to several previous studies, as conducted by 
Alfred et al. (2011) and Lucia et al. (2006). We observed 
the significant correlation between the Δ training volume 
and the ΔVO2peak (mL·kg-1·min-1), i.e. increase in training 
hours related positively to the dynamics of the VO2peak 
(mL·kg-1·min-1). Rusko (1992) has described in his re-
view article that longitudinal studies among skiers have 
referred to the VO2max increase with age and training 
during the 15-20-year-old period, and the annual increase 
may amount up to 1-3 mL·kg-1·min-1 per year. In our 
study, a significant main effect of the VO2peak (mL·kg-
1·min-1) was detected in the total study group, but no 
significant effect was found between the VO2peak (mL·kg-
1·min-1) and the ACE I/D and ACTN3 R577X genotypes 
interactions. 
 
Conclusion 
 
The main result of this study was a significantly higher 
prevalence of the ACE ID and the ACTN3 RR genotypes 
among Estonian young male skiers compared with the 
male control group, which may be an advantage for the 
explosive speed and power capacity in race skiing. Our 
study showed a more remarkable trend of increase in the 
VO2peak (mL·kg-1·min-1) during the 5-year period among 
male skiers with the ACTN3 XX genotype and among 
female skiers with the ACE ID genotype. No significant 
genotype-related associations in the dynamics of the 
VO2peak during the 5-year period were found. 
From a practical viewpoint, the genetic profile 
combined with physiological and biochemical characteris-
tics could form a strong predictive package, which could 
be used by athletes and their teams for personalized man-
agement, monitoring and better optimization of training 
processes in the future. As multiple combinations of gene 
variants influence physical performance phenotypes, 
future longitudinal research, including different gene 
variants, may contribute to a better understanding of the 
nature of physical performance. 
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Key points 
 
• Significantly higher prevalence of the ACE ID and 
the ACTN3 RR genotypes were found among Esto-
nian young male skiers compared with the male 
control group, which may be an advantage for the 
explosive speed and power capacity in race skiing. 
• A more remarkable trend of increase in VO2peak 
(mL·kg-1·min-1) during the 5-year period was ob-
served among male skiers with the ACTN3 XX 
genotype and among female skiers with the ACE 
ID genotype. 
• No significant genotype-related associations in the 
dynamics of VO2peak were found during the 5-year 
period. 
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